Beta-blockers reduce severe exacerbation in patients with mild chronic obstructive pulmonary disease with atrial fibrillation: a population-based cohort study

BACKGROUND AND OBJECTIVE: Beta-blockers (BBs) decrease mortality and acute exacerbation (AE) rates in patients with chronic obstructive pulmonary disease (COPD) and cardiovascular disease; however, information on their effects in patients with COPD and atrial fibrillation (AF) is limited. We aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Shan-Ju, Liao, Xin-Min, Chen, Nai-Yu, Chang, Yu-Ching, Cheng, Ching-Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Chronic Obstructive Pulmonary Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660430/
https://www.ncbi.nlm.nih.gov/pubmed/37989489
http://dx.doi.org/10.1136/bmjresp-2023-001854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660430/
https://www.ncbi.nlm.nih.gov/pubmed/37989489
http://dx.doi.org/10.1136/bmjresp-2023-001854

Ejemplares similares